Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1992 Dec;66(12):7211–7216. doi: 10.1128/jvi.66.12.7211-7216.1992

Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

M Tashiro 1, Y Yokogoshi 1, K Tobita 1, J T Seto 1, R Rott 1, H Kido 1
PMCID: PMC240423  PMID: 1331518

Abstract

Tryptase Clara is an arginine-specific serine protease localized exclusively in and secreted from Clara cells of the bronchial epithelium of rats (H. Kido, Y. Yokogoshi, K. Sakai, M. Tashiro, Y. Kishino, A. Fukutomi, and N. Katunuma, J. Biol. Chem. 267:13573-13579, 1992). The purified protease was shown in vitro to behave similarly to trypsin, cleaving the precursor glycoprotein F of Sendai virus at residue Arg-116 and activating viral infectivity in a dose-dependent manner. Anti-tryptase Clara antibody inhibited viral activation by the protease in vitro in lung block cultures and in vivo in infected rats. When the enzyme-specific antibody was administered intranasally to rats that were also infected intranasally with Sendai virus, activation of progeny virus in the lungs was significantly inhibited. Thus, multiple cycles of viral replication were suppressed, resulting in a reduction in lung lesions and in the mortality rate. These findings indicate that tryptase Clara is an activating protease for Sendai virus in rat lungs and is therefore involved in pulmonary pathogenicity of the virus in rats.

Full text

PDF
7211

Images in this article

7212Image
on p.7212

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akaike T., Molla A., Ando M., Araki S., Maeda H. Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice. J Virol. 1989 May;63(5):2252–2259. doi: 10.1128/jvi.63.5.2252-2259.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blumberg B. M., Giorgi C., Rose K., Kolakofsky D. Sequence determination of the Sendai virus fusion protein gene. J Gen Virol. 1985 Feb;66(Pt 2):317–331. doi: 10.1099/0022-1317-66-2-317. [DOI] [PubMed] [Google Scholar]
  3. Castleman W. L. Alterations in pulmonary ultrastructure and morphometric parameters induced by parainfluenza (Sendai) virus in rats during postnatal growth. Am J Pathol. 1984 Feb;114(2):322–335. [PMC free article] [PubMed] [Google Scholar]
  4. Gething M. J., White J. M., Waterfield M. D. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2737–2740. doi: 10.1073/pnas.75.6.2737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gotoh B., Ogasawara T., Toyoda T., Inocencio N. M., Hamaguchi M., Nagai Y. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J. 1990 Dec;9(12):4189–4195. doi: 10.1002/j.1460-2075.1990.tb07643.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hayashi T., Hotta H., Itoh M., Homma M. Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia. J Gen Virol. 1991 Apr;72(Pt 4):979–982. doi: 10.1099/0022-1317-72-4-979. [DOI] [PubMed] [Google Scholar]
  7. Homma M., Ouchi M. Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol. 1973 Dec;12(6):1457–1465. doi: 10.1128/jvi.12.6.1457-1465.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Homma M. Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of tyrpsin on L cell-borne Sendai virus. J Virol. 1971 Nov;8(5):619–629. doi: 10.1128/jvi.8.5.619-629.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hsu M., Choppin P. W. Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7732–7736. doi: 10.1073/pnas.81.24.7732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ishida N., Homma M. Sendai virus. Adv Virus Res. 1978;23:349–383. doi: 10.1016/s0065-3527(08)60103-7. [DOI] [PubMed] [Google Scholar]
  11. Ito Y., Yamamoto F., Takano M., Maeno K., Shimokata K., Iinuma M., Hara K., Iijima S. Detection of cellular receptors for Sendai virus in mouse tissue sections. Arch Virol. 1983;75(1-2):103–113. doi: 10.1007/BF01314130. [DOI] [PubMed] [Google Scholar]
  12. Itoh M., Ming T. D., Hayashi T., Mochizuki Y., Homma M. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin. J Virol. 1990 Nov;64(11):5660–5664. doi: 10.1128/jvi.64.11.5660-5664.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Itoh M., Shibuta H., Homma M. Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. J Gen Virol. 1987 Nov;68(Pt 11):2939–2944. doi: 10.1099/0022-1317-68-11-2939. [DOI] [PubMed] [Google Scholar]
  14. Kido H., Yokogoshi Y., Sakai K., Tashiro M., Kishino Y., Fukutomi A., Katunuma N. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem. 1992 Jul 5;267(19):13573–13579. [PubMed] [Google Scholar]
  15. Klenk H. D., Rott R. The molecular biology of influenza virus pathogenicity. Adv Virus Res. 1988;34:247–281. doi: 10.1016/S0065-3527(08)60520-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Muramatsu M., Homma M. Trypsin action on the growth of Sendai virus in tissue culture cells. V. An activating enzyme for Sendai virus in the chorioallantoic fluid of the embryonated chicken egg. Microbiol Immunol. 1980;24(2):113–122. doi: 10.1111/j.1348-0421.1980.tb00569.x. [DOI] [PubMed] [Google Scholar]
  17. Nagai Y., Klenk H. D., Rott R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology. 1976 Jul 15;72(2):494–508. doi: 10.1016/0042-6822(76)90178-1. [DOI] [PubMed] [Google Scholar]
  18. Ogasawara T., Gotoh B., Suzuki H., Asaka J., Shimokata K., Rott R., Nagai Y. Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J. 1992 Feb;11(2):467–472. doi: 10.1002/j.1460-2075.1992.tb05076.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rott R. Molecular basis of infectivity and pathogenicity of myxovirus. Brief review. Arch Virol. 1979;59(4):285–298. doi: 10.1007/BF01317469. [DOI] [PubMed] [Google Scholar]
  20. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 1974 Feb;57(2):475–490. doi: 10.1016/0042-6822(74)90187-1. [DOI] [PubMed] [Google Scholar]
  21. Silver S. M., Scheid A., Choppin P. W. Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation. Infect Immun. 1978 Apr;20(1):235–241. doi: 10.1128/iai.20.1.235-241.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tashiro M., Ciborowski P., Reinacher M., Pulverer G., Klenk H. D., Rott R. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology. 1987 Apr;157(2):421–430. doi: 10.1016/0042-6822(87)90284-4. [DOI] [PubMed] [Google Scholar]
  23. Tashiro M., Homma M. Evidence of proteolytic activation of Sendai virus in mouse lung. Arch Virol. 1983;77(2-4):127–137. doi: 10.1007/BF01309262. [DOI] [PubMed] [Google Scholar]
  24. Tashiro M., Homma M. Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun. 1983 Feb;39(2):879–888. doi: 10.1128/iai.39.2.879-888.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tashiro M., James I., Karri S., Wahn K., Tobita K., Klenk H. D., Rott R., Seto J. T. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus. Virology. 1991 Sep;184(1):227–234. doi: 10.1016/0042-6822(91)90839-4. [DOI] [PubMed] [Google Scholar]
  26. Tashiro M., Pritzer E., Khoshnan M. A., Yamakawa M., Kuroda K., Klenk H. D., Rott R., Seto J. T. Characterization of a pantropic variant of Sendai virus derived from a host range mutant. Virology. 1988 Aug;165(2):577–583. doi: 10.1016/0042-6822(88)90601-0. [DOI] [PubMed] [Google Scholar]
  27. Tashiro M., Seto J. T., Choosakul S., Hegemann H., Klenk H. D., Rott R. Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice. J Gen Virol. 1992 Jun;73(Pt 6):1575–1579. doi: 10.1099/0022-1317-73-6-1575. [DOI] [PubMed] [Google Scholar]
  28. Tashiro M., Seto J. T., Choosakul S., Yamakawa M., Klenk H. D., Rott R. Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice. Virology. 1992 Apr;187(2):413–422. doi: 10.1016/0042-6822(92)90443-s. [DOI] [PubMed] [Google Scholar]
  29. Tashiro M., Yamakawa M., Tobita K., Klenk H. D., Rott R., Seto J. T. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J Virol. 1990 Aug;64(8):3627–3634. doi: 10.1128/jvi.64.8.3627-3634.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Toyoda T., Sakaguchi T., Imai K., Inocencio N. M., Gotoh B., Hamaguchi M., Nagai Y. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology. 1987 May;158(1):242–247. doi: 10.1016/0042-6822(87)90261-3. [DOI] [PubMed] [Google Scholar]
  31. Tyrrell D. A., Coid C. R. Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec. 1970 Feb 7;86(6):164–165. doi: 10.1136/vr.86.6.164. [DOI] [PubMed] [Google Scholar]
  32. Webster R. G., Rott R. Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell. 1987 Aug 28;50(5):665–666. doi: 10.1016/0092-8674(87)90321-7. [DOI] [PubMed] [Google Scholar]
  33. Zhirnov O. P., Ovcharenko A. V., Bukrinskaya A. G. Suppression of influenza virus replication in infected mice by protease inhibitors. J Gen Virol. 1984 Jan;65(Pt 1):191–196. doi: 10.1099/0022-1317-65-1-191. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES